preeclampsia Progenity to Close Genetics Lab as Focus Shifts to Therapeutics The firm will no longer offer its Preparent Carrier Test, Innatal Prenatal Screen, Riscover Hereditary Cancer Test, or Resura Prenatal Test. Progenity Q4 Revenues Fall 30 Percent on COVID-19 Effect The firm's revenue decrease was largely driven by a decline in testing volumes due to the COVID-19 pandemic, it said. Progenity Projects 2021 Revenue Growth of Up to 30 Percent The company said it expects core molecular testing revenue between $115 million and $125 million and SARS-CoV-2 revenue between $15 million and $20 million. Progenity Q3 Revenues Increase 38 Percent The company performed 84,067 total tests in Q3 but missed the analysts' average estimates on the top and bottom lines. BTIG Initiates Coverage of Progenity With Buy Rating The investment bank projects medium-term revenue growth in the low teens, thanks to new test launches and expanded payor contracts for the company. Aug 20, 2020 Aiming to Put Regulatory, Payor Issues in Past, Progenity Progresses With Women's Health Pipeline Premium Aug 13, 2020 Progenity Q2 Revenues Fall 70 Percent in First Earnings Report Since IPO Jul 14, 2020 Piper Sandler Initiates Coverage of Progenity With Overweight Rating Jul 1, 2020 Early-Onset Preeclampsia Risk Reflected in Circulating Maternal Transcripts Jun 4, 2020 Igenomix, Ferring Pharmaceuticals Collaborate to Study Infertility, Pregnancy Conditions Oct 23, 2019 Thermo Fisher Scientific, Milu Labs to Develop Mass Spec Assays for Women's Health in China Sep 27, 2019 UCLA Team Using Electrochemical Liquid Biopsy for Placental Testing Under New NIH Grant Premium Jul 31, 2019 Predictive Laboratories, Preeclampsia Foundation Partner to ID Genetic Factors of Condition Apr 18, 2019 Progenity Launches Prenatal Monogenic Disease Screen, Develops New Test Technologies Premium Nov 14, 2018 Pregnancy-Related Immune Changes Revealed by Single-Cell Placenta Sequencing Oct 24, 2018 Preterm Birth Risk, Preeclampsia Exosome Tests Enter Clinical Validation Sep 19, 2018 Pregnancy Microbiomes Vary With Time, Body Site, Disease Jul 25, 2017 Late-Onset Preeclampsia Markers Proposed From Proteomic Study Jun 19, 2017 Fetal Variants Influence Maternal Preeclampsia Risk, New Study Finds Apr 11, 2017 LifeCodexx, Charité Partner on Preeclampsia Detection Assay Aug 26, 2016 Preeclampsia Pathway Complexity Uncovered by Expression Meta-Analysis Jun 16, 2016 Metabolomic Dx Raises €1.6M to Finish Development of Preeclampsia Test Apr 19, 2016 Roche Reports 4 Percent Growth in Diagnostics for Q1 Jan 20, 2016 Roche-Funded Study Validates Pair of Proteins for Predicting Preeclampsia Risk Premium Aug 20, 2015 Team Detects New Immune Alleles With Suspected Pregnancy Effects in Khoe-San Population Load More Breaking News Bruker Posts 34 Percent Jump in Q2 Revenues GenomeWeb Index Gains Slightly in July as Fluidigm, PerkinElmer, Bio-Rad Post Strong Increases Feinstein Institutes for Medical Research Wins $2.9M NIH Grant to Study Polygenic Embryo Screening Top Five Articles on GenomeWeb Last Week: CDC, Bio-Rad, 10x Genomics, PerkinElmer, and More InterVenn Biosciences Closes $201M Series C Round Abcam to Acquire Life Science Research Tool Firm BioVision for $340M The Scan And Back The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database. Lacks Family Hires Attorney A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports. For the Unknown The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona. PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.